GLENSTIM PEG 6MG INJECTION

If you have asthma or any other respiratory condition, it is important to discuss the use of GLENSTIM PEG 6MG INJECTION with your healthcare provider. While there is no specific contraindication for using this medication in patients with asthma, caution should be exercised as the medication may cause respiratory side effects such as shortness of breath or chest tightness.

The most common side effects include bone pain, headache, fatigue, and musculoskeletal pain. Less common side effects include allergic reactions, including anaphylaxis, spleen rupture, acute respiratory distress syndrome (ARDS), and glomerulonephritis.

GLENSTIM PEG 6MG INJECTION and filgrastim are both medications that stimulate the production of white blood cells. However, it is a longer-acting form of filgrastim so it can be given less frequently.

Bone pain is a known side effect of GLENSTIM PEG 6MG INJECTION and may be more common in patients receiving chemotherapy. If you experience bone pain while taking it, contact your healthcare provider.

GLENSTIM PEG 6MG INJECTION is not approved for use in healthy individuals as a preventive measure against infections. It is only approved for use in patients at risk of developing infections due to their underlying medical condition or treatment.

GLENSTIM PEG 6MG INJECTION is primarily used to support patients undergoing cancer treatment by increasing their white blood cell count and reducing their risk of infections. However, it may also be used in other medical conditions where low white blood cell counts are a concern, such as severe chronic neutropenia.

There is no known interaction of GLENSTIM PEG 6MG INJECTION with other drugs.

Remember always to follow your healthcare provider's instructions when taking GLENSTIM PEG 6MG INJECTION or any medication. Patients should be monitored for signs of an allergic reaction, such as rash, itching, or swelling, and should seek immediate medical attention if these symptoms occur. If you have any questions or concerns, do not hesitate to discuss them with your healthcare provider. Be aware of potential side effects and notify your healthcare provider if you experience any unusual symptoms. It should be used with caution in patients with severe renal impairment. Pregnant and breastfeeding women should discuss potential risk and benefit with a healthcare provider before taking this medication. Always maintain a healthy and balanced diet to support your overall health and well-being.

PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR is molecule/combination used for making GLENSTIM PEG 6MG INJECTION.

GLENSTIM PEG 6MG INJECTION is prescribed for ailments/diseases/conditions related to Oncology.